Sbi Securities Co., Ltd. Biogen Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,947 shares of BIIB stock, worth $276,980. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,947
Previous 1,975
1.42%
Holding current value
$276,980
Previous $270 Million
9.52%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BIIB
# of Institutions
1,022Shares Held
131MCall Options Held
2.84MPut Options Held
2.57M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.46 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.25 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.07 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.06 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$683 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...